IFF
62
5
MMC
60
3
EXPD
48
-2
LH
48
2
BLK
61
-2
MSI
47
-2
HOG
38
2
KO
44
2
GWW
65
3
EQR
47
2
PFE
38
2
HBAN
82
2
AN
52
2
F
58
2
CSX
50
2
CMI
73
-2
DIS
72
2
VIX
19
-2
COST
53
5
MTB
75
2
IFF
62
5
MMC
60
3
EXPD
48
-2
LH
48
2
BLK
61
-2
MSI
47
-2
HOG
38
2
KO
44
2
GWW
65
3
EQR
47
2
PFE
38
2
HBAN
82
2
AN
52
2
F
58
2
CSX
50
2
CMI
73
-2
DIS
72
2
VIX
19
-2
COST
53
5
MTB
75
2
Financhill
Back

Themes Cloud Computing ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
55

CLOD
Themes Cloud Computing ETF

Last Price:
$33.20
Seasonality Move:
13.68%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
55
Themes Cloud Computing ETF (CLOD) is a Buy

Is Themes Cloud Computing ETF a Buy, Sell or Hold?

  • The current Themes Cloud Computing ETF [CLOD] share price is $33.04. The Score for CLOD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CLOD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLOD Stock Price Chart

What is Themes Cloud Computing ETF's stock price today?

  • The Themes Cloud Computing ETF share price today is $33.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CLOD is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

CLOD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 44.81 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.43 - 33.79) Sell
Bollinger Bands (100): (33.2 - 35.54) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

CLOD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.92 Buy
20-day SMA: 33.3 Sell
50-day SMA: 34.1 Sell
200-day SMA: 33.05 Sell
8-day EMA: 33.05 Sell
20-day EMA: 33.29 Sell
50-day EMA: 33.81 Sell
200-day EMA: 33.22 Sell

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Themes Cloud Computing ETF Earnings Growth & CLOD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Themes Cloud Computing ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):